Correlation Between Gossamer Bio and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and Vincerx Pharma, you can compare the effects of market volatilities on Gossamer Bio and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and Vincerx Pharma.

Diversification Opportunities for Gossamer Bio and Vincerx Pharma

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Gossamer and Vincerx is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Gossamer Bio and Vincerx Pharma

Given the investment horizon of 90 days Gossamer Bio is expected to under-perform the Vincerx Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Gossamer Bio is 1.59 times less risky than Vincerx Pharma. The stock trades about 0.0 of its potential returns per unit of risk. The Vincerx Pharma is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  174.00  in Vincerx Pharma on August 31, 2024 and sell it today you would lose (146.00) from holding Vincerx Pharma or give up 83.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Gossamer Bio  vs.  Vincerx Pharma

 Performance 
       Timeline  
Gossamer Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gossamer Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Gossamer Bio and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gossamer Bio and Vincerx Pharma

The main advantage of trading using opposite Gossamer Bio and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Gossamer Bio and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Correlations
Find global opportunities by holding instruments from different markets